Status:
COMPLETED
NC Xperience PMCF Study( rEPIC04B)
Lead Sponsor:
Fundación EPIC
Conditions:
Coronary Artery Disease (CAD)
Ischemic Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of NC Xperience to meet EU Medical Device regulation (M...
Detailed Description
The objective of this multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study is to confirm and support the clinical safety and performance of the NC Xperience in a NON-S...
Eligibility Criteria
Inclusion
- Patient treated with NC Xperience according to routine hospital practice and following instructions for use
- Informed consent signed
Exclusion
- Not meet inclusion criteria
Key Trial Info
Start Date :
September 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 5 2023
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT05292105
Start Date
September 26 2022
End Date
May 5 2023
Last Update
January 31 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinic de Barcelona
Barcelona, Spain, 08036
2
Hospital Universitario de Getafe
Getafe, Spain, 28905
3
Hospital Universitario Marques de Valdecilla
Santander, Spain, 39008